Wedbush Downgrades Infinity Pharma To Underperform, Slashes Target To $3 By: Benzinga via Benzinga March 22, 2016 at 13:31 PM EDT Wedbush’s David M. Nierengarten downgraded the rating for Infinity Pharmaceuticals Inc. (NASDAQ: INFI) from Neutral to ... Read More >> Related Stocks: AbbVie Gilead Sciences Infinity Pharmaceuticals